Metrics to compare | ADCI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipADCIPeersSector | |
|---|---|---|---|---|
P/E Ratio | 13.2x | 15.6x | −0.3x | |
PEG Ratio | 0.99 | 0.46 | 0.00 | |
Price/Book | 4.1x | 2.7x | 2.6x | |
Price / LTM Sales | 2.2x | 1.9x | 2.9x | |
Upside (Analyst Target) | - | 22.3% | 62.0% | |
Fair Value Upside | Unlock | 4.0% | 9.5% | Unlock |
The Arab Drug Company engages in the manufacture and sale of pharmaceutical products. The company offers anti parkinsonism, dermatological, cardiovascular, anti-hypertensive, anti-platelets, analgesic, anti-pyretic, anti-inflammatory, antimigraine, topical anti-fungal, respiratory tract, gynecological, anemia and optic atrophy, oral corticosteroid, anesthetics, topical antiviral, antibacterial and anti-infective, anti-acne, nasal decongestants, anti-diarrheal, antihistamines, mucolytics, antiemetic, allergic rhinitis, anti-vertigo, gingivitis, topical anti swelling anti-inflammatory, ovulation stimulants, laxative, and anti-psychotic drugs, as well as mouth wash, cosmetics, and moisturizing products. It also provides products for animal health. The company exports its products to China, Korea, Turkey, Kazakhstan, Iraq, Syria, Jordan, Lebanon, Libya, Sudan, Somalia, Yemen, and Morocco. The Arab Drug Company was founded in 1963 and is based in Cairo, Egypt.